The National Kidney Foundation joined drugmakers and dialysis providers in opposing a measure in Congress that would extend Medicare coverage beyond 36 months for immunosuppressant drugs given to patients after a kidney transplant because they say it would be paid for by reducing reimbursements to dialysis patients. Kidney Care Partners, a coalition of dialysis providers, drugmakers and others, said although the bundled-payment method would help one group of patients, it "would potentially put another very vulnerable group of patients at risk."

Full Story:

Related Summaries